These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 16820335)

  • 41. HIV-specific differences in outcome of squamous cell carcinoma of the anal canal: a multicentric cohort study of HIV-positive patients receiving highly active antiretroviral therapy.
    Oehler-Jänne C; Huguet F; Provencher S; Seifert B; Negretti L; Riener MO; Bonet M; Allal AS; Ciernik IF
    J Clin Oncol; 2008 May; 26(15):2550-7. PubMed ID: 18427149
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Clinical impact of GB virus C viremia on patients with HIV type 1 infection in the era of highly active antiretroviral therapy.
    Sheng WH; Hung CC; Wu RJ; Wang JT; Chen PJ; Chang SC; Kao JH
    Clin Infect Dis; 2007 Feb; 44(4):584-90. PubMed ID: 17243064
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Dyspepsia in HIV-infected patients under highly active antiretroviral therapy.
    Werneck-Silva AL; Prado IB
    J Gastroenterol Hepatol; 2007 Nov; 22(11):1712-6. PubMed ID: 17559368
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Antiretroviral therapy improves cognitive impairment in HIV+ individuals in sub-Saharan Africa.
    Sacktor N; Nakasujja N; Skolasky R; Robertson K; Wong M; Musisi S; Ronald A; Katabira E
    Neurology; 2006 Jul; 67(2):311-4. PubMed ID: 16864825
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Superior virological response to boosted protease inhibitor-based highly active antiretroviral therapy in an observational treatment programme.
    Wood E; Hogg RS; Yip B; Moore D; Harrigan PR; Montaner JS
    HIV Med; 2007 Mar; 8(2):80-5. PubMed ID: 17352763
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Low rates of antiretroviral therapy among HIV-infected patients with chronic kidney disease.
    Choi AI; Rodriguez RA; Bacchetti P; Volberding PA; Havlir D; Bertenthal D; Bostrom A; O'Hare AM
    Clin Infect Dis; 2007 Dec; 45(12):1633-9. PubMed ID: 18190326
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Retention in opioid substitution treatment: a major predictor of long-term virological success for HIV-infected injection drug users receiving antiretroviral treatment.
    Roux P; Carrieri MP; Cohen J; Ravaux I; Poizot-Martin I; Dellamonica P; Spire B
    Clin Infect Dis; 2009 Nov; 49(9):1433-40. PubMed ID: 19807275
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Herpes viruses in periodontal compromised sites: comparison between HIV-positive and -negative patients.
    Grande SR; Imbronito AV; Okuda OS; Lotufo RF; Magalhães MH; Nunes FD
    J Clin Periodontol; 2008 Oct; 35(10):838-45. PubMed ID: 18727655
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Control of HIV/AIDS and AIDS-related conditions in Africa with special reference to periodontal diseases.
    Reddy J
    J Int Acad Periodontol; 2007 Jan; 9(1):2-12. PubMed ID: 17274234
    [TBL] [Abstract][Full Text] [Related]  

  • 50. A review of candida and periodontal disease in immunocompetent and HIV-infected subjects.
    Feller L; Buskin A; Blignaut E
    SADJ; 2005 May; 60(4):152-4. PubMed ID: 15974431
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Clinical effect of use of biopolymer films in the complex treatment of the chronic general periodontitis].
    Kandelaki KT
    Georgian Med News; 2005; (124-125):60-4. PubMed ID: 16148381
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Comparative periodontal status of human immunodeficiency virus-positive patients and controls in a dedicated human immunodeficiency virus clinic in Nigeria.
    Umeizudike KA; Ayanbadejo PO; Savage KO; Nwhator SO; Akanmu AS; Ogunleye O
    Niger J Clin Pract; 2016; 19(1):35-40. PubMed ID: 26755216
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Cutaneous warts in HIV-positive patients undergoing highly active antiretroviral therapy.
    Rodrigues LK; Baker T; Maurer T
    Arch Dermatol; 2001 Aug; 137(8):1103-4. PubMed ID: 11493111
    [No Abstract]   [Full Text] [Related]  

  • 54. Comparison of periodontal disease in HIV seropositive subjects and controls (I). Clinical features.
    Smith GL; Cross DL; Wray D
    J Clin Periodontol; 1995 Jul; 22(7):558-68. PubMed ID: 7560240
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Periodontal status of HIV-infected patients undergoing antiretroviral therapy compared to HIV-therapy naive patients: a case control study.
    Fricke U; Geurtsen W; Staufenbiel I; Rahman A
    Eur J Med Res; 2012 Jan; 17(1):2. PubMed ID: 22472296
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Linear gingival erythema in an HIV-seropositive man.
    Lugo RI; Fornatora ML; Reich RF; Freedman PD
    AIDS Read; 1999; 9(2):97-9. PubMed ID: 12728891
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Does HIV serostatus affect outcomes of dually diagnosed opiate dependents in residential treatment?
    Carra G; Montomoli C; Monti MC; Clerici M
    Epidemiol Psichiatr Soc; 2008; 17(1):77-81. PubMed ID: 18444461
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Planning therapy for the periodontal pocket.
    Klavan B
    J Acad Gen Dent; 1971 Jul; 19(4):10-5. PubMed ID: 5283866
    [No Abstract]   [Full Text] [Related]  

  • 59. A simple scoring system predicted clinical progression in HIV patients receiving highly active antiretroviral therapy.
    Bender B
    ACP J Club; 2002; 137(1):37. PubMed ID: 12093236
    [No Abstract]   [Full Text] [Related]  

  • 60. [The method of stimulation of regenerative processes during inflammatory-destructive periodontal diseases].
    Molokov VD; Vasil'eva LS; Kolesnikov SI; Malyshev VV
    Biull Eksp Biol Med; 1998 Mar; 125(3):357-60. PubMed ID: 9606566
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.